Tumor-derived CD109 orchestrates reprogramming of tumor-associated macrophages to dampen immune response. Cui T, Sun L, Guo X, Cheng C, et al. J Hepatol 2025;83:946-958.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cui T, Sun L, Guo X, Cheng C, et al. Tumor-derived CD109 orchestrates reprogramming of tumor-associated macrophages to dampen immune response. J Hepatol 2025;83:946-958.
PMID: 40220905